Skip to main content
Equibles

SCOTIA CAPITAL INC.

Position in EDSA — Edesa Biotech, Inc.

CIK 1335644 TORONTO, A6
Back to EDSA Full portfolio

Position in EDSA

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$117,015
+$34,157 QoQ
Shares Held
14,393
-9.2% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 33 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in EDSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCOTIA CAPITAL INC. holds $19,756,450 across 14 Biotechnology names. EDSA ranks #10 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EPRX
Eupraxia Pharmaceuticals Inc.
 1,343,726 $8,882,028
2 BNTX
BioNTech SE
 45,000 $4,187,250
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,981 $3,467,672
4 DFTX
Definium Therapeutics, Inc.
 34,722 $1,633,322
5 EYPT
EyePoint, Inc.
 41,751 $597,039
6 VKTX
Viking Therapeutics, Inc.
 6,031 $235,269
7 ABCL
AbCellera Biologics Inc.
 25,082 $196,893
8 OCUL
Ocular Therapeutix, Inc
 13,337 $130,969

All Filings in EDSA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $117,015 14,393
2026-03-31 $82,858 15,843